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INTRODUCTION 
 
      As we know, the benign conditions of liver have lots of clinical 
implications. Of these, liver abscess is a common condition worldwide 
particularly in the tropical countries. Among the developing countries, India has 
2nd highest incidence of liver abscess in the world. There are many pre 
disposing factors for liver abscess. The infective agents causing liver abscess 
can be classified as bacterial, parasitic or fungal causes. Among all, pyogenic 
abscesses accounts for four fifth of liver abscess in developed countries, 
whereas amoebic liver abscess account for two third of liver abscess in 
developing countries. 
      Entemoeba histolytica infection affects 10% of world population , 
pyogenic liver abscess affects 30/1,00,000 hospital admissions and the sex 
incidence is almost equal .  
          The management of amoebic liver abscess evolved with recognition 
of colonic  amebiasis as the antecedent source of liver abscess. Early treatment 
with open surgical drainage alone had met with limited success .  Efforts to 
treat both liver abscess and colonic infestation improved the success rate. 
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     With the development of systemic amoebicidal agents along with USG 
guided closed aspiration became the treatment of choice. The present 
laparoscopic era has narrowed down open procedure .  
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AIMS AND OBJECTIVES 
 
1. To study the clinical presentation of liver abscesses i.e. Distribution 
with respect to age and sex, mode of presentations. 
2. To study the  risk factors associated with liver abscess . 
3. To study the microbiological diversity in liver abscess . 
4. To study the effectiveness of various treatment modalities for liver 
abscess . 
5. To study the effectiveness of different modes of management. 
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REVIEW OF LITERATURE 
 
Historical aspects 
       The history of amoebiasis goes back to  the era of Indian great 
Susruta (600 BC) who gave description of amoebic dysentery as Athisara, 
incriminating the germination of parasites in the intestines by drinking 
impure water.  
      Liver abscess was first drained in the Hippocratic era, and master of 
medicine successfully practiced the draining of pus. 
      The parasite was first described by Lambi and was demonstrated in pus 
from the tissues adjoining the liver abscess by the microbiologist Koch. 
Councilman and Lafleur (1891) in Baltimore proved the clinical and 
pathological evidence that amoeba was responsible for liver abscess. 
      Roger (1918) in his famous paper described “The protozoal organism 
reaches the liver by portal circulation and they entangle in the interlobular 
veins producing congestion of liver, he established that amoebae are 
constantly present in the walls of the abscess though not frequently in pus.” 
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SURGICAL ANATOMY 
 
 
The liver, the largest gland in the body weighs approximately 1500g 
and receives about 1800 ml of blood /min. This wedge shaped organ 
occupies most of the right hypochondrium and epigastrium. It has two 
surfaces, visceral and diaphragmatic. 
The diaphragmatic surface, convex is divided into anterior, posterior 
and right surfaces. Sharp inferior border separates right and anterior surface 
from visceral surface. 
The main vessels and ducts enter or leave at the porta hepatis which is on 
the visceral surface, but hepatic vein emerges from the diaphragmatic 
surface. 
The inferior border is notched by the ligamentum teres. The falciform 
ligament ascends on the anterior surface to reach the superior surface where a 
reduplication of the left leaf forms the left triangular ligament. The right leaf 
becomes the upper layer of the coronary ligament. 
The venacava lies in the deep groove on the posterior surface. To the 
right is the triangular bare area, with the vena cava at its base and with 
sides formed by superior and inferior layers of coronary ligament. The apex 
where these two layers meet is the right triangular ligament. 
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Surgical Anatomy of Liver – Diaphragmatic surface and visceral surface 
 
Couinaud’s functional segments of Liver 
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At the porta hepatis, lie the hepatic ducts, hepatic artery and portal 
vein. They lie in the order  vein-artery-duct, with the duct in front. There 
are also nodes and nerves of the liver. The bare area is in contact with the 
diaphragm and right suprarenal gland. 
The visceral surface is related to stomach, duodenum, hepatic flexure 
of colon and right kidney. 
Anatomically the liver has two lobes, right and left divided by the 
falciform ligament anteriorly. The right lobe is further divided into right 
lobe proper, caudate and quadrate lobes. The caudate lobe lies in between 
IVC and fissure for ligamentum venosum. The quadrate lobe lies in the 
visceral surface between the gallbladder fossa and fissure for ligamentum 
teres. 
 
SEGMENTS OF LIVER 
 
On the basis of blood supply and biliary drainage there are four main 
hepatic sectors: left lateral, left medial, right anterior and right posterior 
.These four sectors further subdivided into eight segments. 
SEGMENT 1 - caudate lobe - An autonomous segment receiving blood 
from right and left branches of hepatic artery and portal vein, draining bile  
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ANATOMY OF A LIVER LOBULE 
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into right and left hepatic ducts and having independent venous drainage 
into 1VC. 
The left lateral sector contains segment Il posteriorly, segment Ill 
anteriorly with the left hepatic vein between them. 
       Segment IV is recognized on the visceral surface as the quadratelobe. 
Segment V and VI are the inferior segments of the right anterior and 
posterior sectors respectively. Segments VII and VIII are the superior 
segments of the right posterior and anterior sectors respectively. 
HISTOLOGY 
 
Liver is seen to be composed of parenchymal cells arranged in 
anastomosing and branching plates which form a three dimensional lattice. 
Plates of parenchymal cells radiate from central vein like spokes of a 
wheel, each being 1 mm in diameter. Portal triad or portal areas or portal 
canal contains a branch of portal vein, a branch of hepatic artery and an 
interlobular bile ductule. 
In humans, liver contains 3-6 portal canals per lobule. Between 
parenchymal plates are sinusoidal blood spaces. Sinusoids are irregularly 
disposed, normally in a direction perpendicular to the lines connecting 
central veins. Walls of the sinusoids consist of endothelial cells called 
Kupffer cells. Potential spaces between hepatic cells and walls of sinusoids 
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are called space of Disse. This space is continuous with larger space that 
surrounds the portal areas known as the space of Moll. 
The continuous liver tissue is pervaded by two systems of tunnels, 
the portal tracts and hepatic canals, which are arranged in such a way that 
they do not meet each other. As far as possible two systems run in planes 
perpendicular to each other. The terminal branches of portal vein discharge 
their blood into sinusoids. 
PYOGENIC LIVER ABSCESS: 
Incidence: 
      Pitt and Zuidema, in 1973, documented an admission prevalence at 
the Johns Hopkins Hospital, Baltimore of 13 per 1,00,000 A more recent 
publication from that same institution comparing a pair of 21-year time 
periods suggests that the incidence of pyogenic hepatic abscesses has 
increased significantly to 20 per 1,00,000 admissions(1). In a series from 
Duke University Medical center, the incidence over period 1979 to 1986 
was 22 cases per 1,00,000 hospital admissions. This compared with a 
figure of 11.5 cases per 1,00,000 admission during the period 1970 to 1978. 
A further series from university of California San Francisco Hospital 
describes an incidence of 22 cases per 100000 hospital admissions. In each 
of these series, the peak incidence occurred early in sixth decade thereby 
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suggesting a shift in age. In two of these series, the most common cause of 
hepatic abscess was found to be cryptogenic in that no obvious 
predisposing cause was identified. It remains possible that there has been a 
recent true increase in the incidence of primary cryptogenic PLA. 
Etiology and Pathogenesis: 
 Most pyogenic liver abscesses are caused by infection in biliary or 
intestinal tracts. As a result, the causes of liver abscesses have been divided 
into six categories based on the route of extension of infection. 
1. Biliary- from ascending cholangitis. 
2. Portal vein- as in pyelophlebitis resulting from appendicitis or 
diverticulitis. 
3. Hepatic artery- from septicemia. 
4. Direct extension- from contiguous disease process 
5. Traumatic- from blunt or penetrating injuries 
6. Cryptogenic- when no primary source of infection is found even 
after abdominal exploration of autopsy. 
In the 1975 report by Pitt and Zuidema from the Johns Hopkins 
Hospital, 51% of the patients had a hepatobiliary or pancreatic neoplasm 
(23%) or a benign biliary tract condition (28%) [1]. However in the more 
recent series from Johns Hopkins, the underlying problem was a malignant 
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disease in 42% of patients. Similar trends have been reported by Branum 
and Associates at Duke University in North Carolina. 
Analysis of abscesses with a portal cause reveals that several other 
intra abdominal disease process have replaced appendicitis as the leading 
cause in this category. At present, the frequent sources of portal vein sepsis 
resulting in liver abscess include diverticulitis, perforated ulcers, and 
perforated carcinomas. The relative incidence of pyogenic liver abscesses 
resulting from systemic bacteremia, direct extension, and trauma have 
remained relatively constant since 1950. 
The pathogenesis of cryptogenic abscesses is still uncertain, although 
several theories have been proposed. In 1972, Lee and Block noted an 
increased incidence of anaerobic infections in their patients. They 
suggested that cryptogenic abscesses may develop from small areas of 
intrahepatic thromboembolim or infarction that become infected 
secondarily by anaerobic bacteria was present in 45% of all liver abscesses, 
the most commonly encountered organisms were anaerobic and 
microaerophilic streptococci, bacteroides fragilis and fusobacterium. 
Patients with compromised host defenses have an increased risk of 
developing pyogenic liver abscesses. Diabetes mellitus was present in 15% 
of the patients of Altemeier et al, and liver abscesses have been found in 
 18
children with leukemia, chronic granulomatous disease, AIDS and other 
immunodeficiency disorders. 
Pathology: 
Generally, portal, traumatic, and cryptogenic liver abscesses are 
solitary and large, while biliary and arterial abscesses are multiple and 
small. If the primary lesion is located within the portal circulation, usually 
the’ abscesses are large, single or multiple and in most cases confined to 
the right lobe of liver, the left lobe is rarely affected.  
Kinney and Ferrebee’ in a study based on experiments of serege in 
190118, showed that there is a separate flow of blood from superior 
mesenteric vein to the right lobe of the liver, and from splenic vein to the 
left lobe of the liver[3] . This explains the preferential location of portal liver 
abscesses in the right lobe, which drains the intestines. Liver abscesses in 
both lobes will occur when the portal vein is filled with a septic thrombus. 
In a review by Gyorff’ and colleagues, 40% of the liver abscesses 
were found to be 1.5 to 5 cm in diameter, 40% were 5 to 8 cm, and 20% 
were 8 cm or larger[4]. Pyogenic liver abscesses localize to the right hepatic 
lobe in 65% cases, with the majority of these being solitary. The left lobe is 
solely involved in 12% of cases, with 23% of patients having bilateral 
abscesses. Bilateral disease occurs in 90% of cases with a biliary or arterial 
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source of infection distributing along the terminal branches of the portal 
triad. Fungal hepatic abscesses are most often multiple bilateral, and 
miliary in nature. 
Microbiology: 
On older literary evidence, sterile culture was found in up to 60% of 
all cases. Even in more recent reviews, the number of sterile abscesses still 
exceeds 10%. This low number is probably the result of inadequate 
anaerobic culture techniques. In a systematic search, Sabbaj & Co-workers 
found that anaerobic bacteria were present in 45% of all liver abscesses, the 
most commonly encountered organisms were anaerobic and 
microaerophilic streptococci, Bacteroides fragilis, and fusobacterium[5]. 
The observations of Onderdonk et al that the presence of anaerobic 
bacteria is necessary to produce intraperitoneal abscesses, it is likely that 
anaerobic bacteria are involved in a large percentage of hepatic       
abscesses [6]. It seems, that anaerobic bacteria are prominent in abscesses, 
secondary to hepatic tumors, and that the bacteriology of abscesses 
originating from lesions within the portal circulation closely resembles that 
of intraperitoneal infections, that is E. Coli, Enterococcus and Bacteroides.        
Most tuberculosis lesions of the liver are miliary granulomas. 
Abscess like masses (Tuberculomas) sometimes form and spread along the 
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walls of the intrahepatic bile ducts (tuberculous cholangitis). Diagnosis 
may be difficult because both caseation and acid fast organisms can be 
absent. Tuberculomas are often, but not always, accompanied by an 
abdominal focus. 
Miliary abscesses have been found in cases of disseminated 
granuloma inguinale. Hepatic clostridial infections cause gas abscesses, but 
most of the jaundice in disseminated infections is hemolytic. 
Clinical Features 
Most patients with pyogenic liver abscesses present with symptoms 
of less than 2 weeks duration. The most common presenting symptom is 
fever, which is noted in approximately 90% of patients. Pain is the next 
common symptom. Chills and weight loss occur in approximately one half 
of the patients, other symptoms like jaundice, diarrhoea, cough, anorexia 
can also be present. 
The most common physical sign is an enlarged tender liver, which is 
found in 55% patients with pyogenic abscess. Jaundice is also found on 
physical examination in approximately one half of the patients. Chest 
symptoms and physical findings are found in approximately one fourth of the 
patients. Abdominal examination reveals a palpable mass or ascites in about 
25% of patients where as splenomegaly is detected in only 10%. 
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Almost all patients with pyogenic liver abscess have abnormal 
hematological and liver function tests. Leucocytosis is noted in approximately 
70 to 90% of patients. Many patients are also found to be anaemic and this 
usually reflects the presence of chronic disease or a prolonged sub acute 
presentation. Erythrocyte sedimentation rate is also elevated. The most frequent 
liver function test abnormality observed in patients with hepatic abscess is an 
elevated alkaline phosphatase. This is seen in approximately 80 -90% of 
patients. Bilirubin is elevated in 40-60% of patients. Transaminases are also 
abnormal. Hypoalbuminemia is observed in approximately 70% of patients and 
mild elevation of prothrombin time is also frequently seen. 
Radiological investigations: 
Chest radiographs are abnormal in approximately 50% of patients 
presenting with hepatic abscesses. Changes suggestive of sub-diaphragmatic 
pathology include an elevated right hemi diaphragm; a right pleural effusion 
and right lower lobe atelectasis. Similar findings are occasionally found in the 
left thoracic cavity if the abscess involves the left hepatic lobe. 
       If gas-forming organisms are present within the abscess and air fluid 
level may be seen. Air within an unoperated biliary tree may also be 
demonstrated, confirming the diagnosis of cholangitis. Rarely portal venous gas 
may be seen on an abdominal x-ray, confirming pyelophlebitis. Portal venous 
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gas appears as branching linear lucencies along the peripheral portion of the 
liver. Air within the biliary tree tends to be seen more centrally. However, it is 
rarely possible to make this distinction on the basis of plain film appearances 
alone and US or CT are usually required. 
      With the increased incidence of biliary causes of pyogenic liver abscess 
cholangiography has become more important in the diagnosis of many of these 
patients. Either ERCP or MRCP were helpful in defining biliary anatomy as 
well as in outlining the abscess cavities in approximately two third of the 
studies 
Satiani and Davidson found liver scans to be positive in 90% of 
patients with a solitary abscess but in only 70% of patients with a multiple 
abscesses[7]. The decreased accuracy of liver scanning in patients with multiple 
abscesses is explained by the finding that abscesses smaller than 2cm are not 
detected by this technique. A liver scan with technetium-99 sulfur colloid will 
show the defect in over 80% of all cases. Other radiologic methods, such as 
scanning with indium Ill labelled leucocytes and gallium 67 are used.  
Liver scans have provided a means for early detection of abscesses that 
was not previously available.  
Barreda and Ros considered Ultrasonogram to be modality of choice in 
studying the internal nature of hepatic abscesses [8] . 
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The disadvantages are: 
1. Cannot always visualize the liver dome and may miss lesions in this 
area 
2. Multiple microscopic abscesses such as those generally found with 
ascending cholangitis, may not be appreciated. 
3. Fatty infiltration may produce a markedly echogenic liver, with 
resulting failure to detect a small abscess. 
USG and CT of abdomen have replaced liver scans as the method of 
choice for radiologic proof of hepatic abscesses. Abscesses that are large 
enough to be suitable for diagnostic aspiration or therapeutic drainage can be 
equally well diagnosed ultrasonography the lesion can be echogenic as well as 
nonechogenic. In the case of non-echoic lesions variable amounts of internal 
echo can be seen. Nearly all abscesses show distal sonic enhancement as long 
as no gas is present. Computed tomography may visualize hepatic collections as 
small as 0.5cm and CT may more easily identity multiple small abscesses. Most 
abscesses are inhomogeneous, but the density is generally lower than in the 
surrounding tissue. Intravenous administration of contrast material enhances the 
case by which abscesses can be diagnosed, and in a few cases the abscess 
cannot be detected until the contrast material has been administered. MRI has 
recently been used for the detection of hepatic abscesses. 
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TREATMENT 
Once a diagnosis of hepatic abscess is suspected broad spectrum 
intravenous antibiotics should be started. Antibiotics therapy can be adjusted 
once the results of abscess cultures are available.  Blood should also be sent for 
culture. Specimens should be cultured for acid —fast bacilli and fungi and this 
is particularly the case if there is a clinical suspicion of mycobacterium or 
fungal infections or if patients are immune suppressed. Empirical antibiotic 
therapy should include effective cover against aerobic gram-negative bacteria. 
Appropriate antibiotic combination would include ampicillin and 
aminoglycoside and metronidazole or a third generation cephalosporin such as 
cefotaxime together with ampicillin and metronidazole, alternatively a 
carbapenem antibiotic such as imipenem or meropenem may be used. 
Metronidazole will also be therapeutic for patients with amoebic liver abscess. 
All patients at risk of amoebic liver abscess should also undergo serological 
testing. 
The duration of antibiotic treatment will vary according to the clinical 
setting. However antibiotic penetration into the abscess cavity is often poor 
and 2 weeks of intravenous antibiotics are usually recommended. Appropriate 
oral antibiotics are usually continued for a further 4 weeks. 
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In the pre-antibiotic era, untreated liver abscess was uniformly fatal. 
Following the publication of the review by Ochsner et al in 1938, surgical 
drainage was widely adopted and this resulted in dramatic reduction in 
mortality. Extra peritoneal drainage was recommended so as to avoid 
contamination of the peritoneal cavity. This was usually achieved via a 
posterior approach through the undersurface of the twelfth rib.  
 In 1985, Gerzof et al 27 published a series of 18 hepatic abscesses, 16 of 
which were successfully managed by percutaneous catheter drainage[9]. Only 
two patients required surgical drainage and no deaths were reported in this 
series. The following year Bertel et al 40 (1986) published a series 39 patients 
with pyogenic hepatic abscess; 23 patients were treated surgically, 16 patients 
underwent percutaneous drainage. Three of the percutaneously treated group 
required surgical drainage due to viscous abscess contents. However, the 
majority of patients were successfully treated. Mortality was 17% in the 
surgical group and 13% in percutaneoulsy-drained group [10]. Wong (1990) ‘“ 
described 21 patients with pyogenic liver abscess treated by percutaneous 
drainage[11]. This was successful in 85% of patients with mortality of less than 1 
0%. Contraindications to catheter drainage include the presence of ascites, 
coagulopathy and proximity to vital structures.  
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Branum et al (1990) reported a series of 73 patients admitted between 
1970 and 1986. During the period 1970 to 1978, 86% of patients (25 of 29) 
were initially treated by surgery. However, during the period 1971 to 1986, 
equal numbers of patients underwent surgery and percutaneous drainage as the 
first definitive therapy[12]. 
In 1996, Seeto and Rockey reported a series of 142 patients admitted 
between January 1979 and December 1994. During the first 3 years of this 
study 925 of patients (12 of 13) were initially treated by surgery. However, 
during the last 5 years of the study only I of 50 patients underwent surgery as 
the initial form of treatment. Percutaneous drainage was successful in 90% of 
these patients[13]. 
It has recently been suggested that percutaneous aspiration may be 
preferable to catheter drainage. The main advantages of needle aspiration over 
catheter drainage are the fact that it is less invasive, less expensive and needle 
aspiration avoids the problems related to follow-up catheter care or loss of 
catheter position. However, incomplete evacuation of the abscess cavity or 
rapid reaccumulation of abscess contents following percutaneous aspiration was 
considered indications for continuous catheter drainage. Percutaneous needle 
aspiration appeared to be less effective than PCD, though both procedures were 
shown to be safe with no major complications and no deaths. 
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Therapy with antibiotics alone may be appropriate in selected patients. 
For example, patients with malignant biliary obstruction and pyogenic liver 
abscess may be successfully managed with a combination of biliary 
decompression in these patients is invariably fatal irrespective of whether 
abscess drainage is performed or not[26]. 
It was initially thought that only patients with single PLA should be 
managed by percutaneous drainage with operative drainage reserved for 
patients with multiple or complex abscess. However, a number of authors have 
found that percutaneous treatments are equally effective for patients with both 
single and multiple pyogenic abscesses.  
Liver resection is occasionally required for patients with pyogenic liver 
abscess. The indication for this is usually hepatolithiasis or intrahepatic biliary 
stricture. In other patients, hepatic destruction may be so severe that they are 
best served by liver resection. Clearly risks are involved as manipulation may 
produce a life-threatening bacteremia. it is therefore recommended that, 
following ligation of the vascular inflow, the involved hepatic vein should be 
ligated before parenchymal dissection is carried out. 
Laparoscopic drainage is an attractive alternative for patients requiring 
open surgical drainage. The advantages of laparoscopic surgery in terms of 
reduced analgesia requirements, reduced morbidity, faster postoperative 
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recovery and shorter hospital stay compared to laparotomy are well 
documented. Laparoscopic US is also likely to be useful in this respect.  
Outcome: 
With the introduction of surgical drainage and systemic antibiotics 
mortality fell. In the 1980s, the widespread availability of US and CT facilitated 
earlier diagnosis and the development of percutaneous methods of drainage. 
This has resulted in a further fall in mortality. In the Johns Hopkins series, the 
overall mortality in the period 1952 to 1972 was 65% compared to a mortality 
of 31% during the period 1972 to 1993. Branum et al (1990) have reported a 
mortality of 19% between 1970 and 1986 [12] and most recently Seeto and 
Rockey (1996)6 have reported a mortality of 11% for patients presenting 
between 1979 and 1994 [13]. 
A number of studies have attempted to identify factors that are predictive 
of poor outcome. In a univariate analysis, Lee et al (1991)36 identified clinical 
jaundice, pleural effusion and bilobar abscesses to be risk factors for mortality 
were hypoalbuminemia, hyperbilirubinemia, elevated aspartate transferase and 
alkaline phosphatase and leukocytosis. Multivariate analysis revealed 
leukocytosis, hypoalbuminemia and pleural effusion to be independent risk 
factors for mortality. A multivariate analysis of 46 patients from Austria found 
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that a high bilirubin, low hemoglobin, and a high APACHE I score were 
predictors of a complicated clinical course or mortality[14].  
 Perforation of hepatic abscess was predictive of a complicated clinical 
course with a mortality of 3.07%. Chou et al (1994)48 also found that rupture 
of pyogenic liver abscess was associated with a significantly higher mortality 
(43.5% compared to 15.5%). In a considerably larger series of 384 patients, 
Chou et a (1994) identified age greater than 60, impaired renal function, 
hypoalbuminemia and elevated bilirubin to be independent risk factors of 
mortality [15].  
     The incidence of pyogenic liver abscess appears to be increasing. This is in 
part due to a more aggressive approach to the treatment of patients with 
hepatobiliary and pancreatic malignancy and the increasing use of cytotoxic 
drugs. Uncomplicated pyogenic liver abscess is now a disease with a good 
prognosis. This is illustrated by the fact that patients with cryptogenic liver 
abscess may have mortality as low as 2%.66 Factors such as delayed 
presentation and delayed diagnosis may both contribute to poor outcome. 
However, the major factor now contributing to mortality in patients with 
pyogenic liver abscess is the severity of the underlying disease and in particular 
the presence of malignancy.  
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AMOEBIC LIVER ABSCESS 
EPIDEMIOLOGY 
Infection with E. histolytica affects one tenth of the world’s population 
and is considered responsible for at least 40,000 deaths annually, most 
infections occurring in the developing countries of the tropics and subtropics. 
Infection prevalence varies greatly and in some regions exceeds 
50%. One study from Gambia, West Africa documented infection rates 
approaching 100% annually[16]. 
The new organisms that have been described among the entamoebae 
species are E. Moshkovskii and E.Dispar .They have been described in Indian 
population.  
The association between amebiasis and warm climates results from the 
poor sanitation and lack of hygiene that accompany poor living conditions. 
Infection occurs mainly by the fecal- oral route. Contaminated food, unhygienic 
handling of food and raw sewage contamination water supplies occasionally 
causes  infection. 
 “Person-to-person spread as may occur in institutions or in slum areas 
with large immigrant population accounts for most cases. In occasional 
patients, no source of infection is evident[17,18,19]. 
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LIFE CYCLE OF E.HISTOLYTICA 
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Microbiology: 
     The protozoan E. histolytica belongs to the subphylum Sarcodina (whose 
motility depends on pseudopodia), the superclass Rhizopoda and the order 
Amoebida. The genus Entamoeba includes the species E. histolytica, E. 
bartmanni (a non-invasive ‘small race’ with cysts <10 tm in diameter), E coil, E 
polecki (infects pigs) and E. moshkovski (a free-living non-pathogenic form 
found in sewage). Except for E. histolytica, the other species are regarded as 
non-pathogenic. With the discovery of E.dispar, the identification of E. 
histolytica on morphology has become unreliable. The presence of ingested 
erythrocytes is seen only with E. histolytica. The two species have now been 
characterized by the study of zymodemes (patterns of electrophoretic mobility 
of isoenzymes) and genetic differences using RNA and DNA probes, and the 
use of polymerase chain reaction amplification. 
E. Histolytica has two forms: Trophozoite and cyst. The Trophozoites are 
uninucleate, facultative anaerobes with a double-layered limiting membrane 
surrounded by a fuzzy, external 20-30 nn glycocalyx. With the emerging 
concepts of virulence, it appears that only certain strains of E. hisiolytica are 
capable of tissue invasion and contact lysis of cells. 
Using the electrophoretic patterns of amoebic enzymes such as glucose- 
phosphate isomerase, I -malate, NADP oxidoreductase, phosphoglucomutase 
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and hexakinase, 18 zymodenes of E. histolytica have been described from 
various areas of the world. Seven of these strains have been isolated from 
subjects with mucosal ulceration and liver abscess and are consequently labeled 
as pathogenic. 
Cysts of E. histolytica are quadrinucleate. These cysts, measuring 8-
20 um, are an important identifying feature, and constitute the infective form of 
the organism. They are responsible for fecal-oral transmission via food, water 
or direct person-to-person contact. After ingestion, the quadrinucleate cysts 
reach the intestinal tract, where they develop into a metacystic stage and 
undergo an additional nuclear division; thus, eight new uninucleate trophozoites 
emerge to complete the life cycle. Cysts survive up to 45 minutes in fecal 
material lodged under the finger nails and up to 1 month in soil at 10°C. They 
remain infective in fresh water, sea water and sewage but are rapidly destroyed 
by drying, 200 p.p.m. of iodine and heat above 68°C. They are not killed by 
chlorination used to purify ordinary drinking water[20]. 
Host factors 
The human host represents the major reservoir although cross-infection 
from animals - particularly monkeys and rodents has been postulated. 
Interpersonal transmission occurs via files and handles, and by sewage 
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contamination of water sources. Male homosexuals also transmit the disease, 
but usually harbor non- pathogenic E. dispar[21]. 
A high content of iron in the diet, often obtained from country liquor, 
predisposes to invasive amoebiasis, and also diet rich in carbohydrate. Young 
adult males of low socio-economic status are thus the most commonly affected 
group. Elderly individuals with underlying diseases, and patients with 
depressed immunity due to malnutrition or corticosteroid therapy, are also 
prone to invasion by amoebae. The natural resistance of menstruating women is 
lost in pregnancy. 
In Mexican Mestizo population the presence of HLA DR3 and 
complotype SCO in both adults and children constitutes a primary independent 
risk factor for the development of amoebic liver abscess, irrespective of age or 
sex. 
Pathogenesis  
Entamoeba histolytica exerts a lytic effect on tissue, a characteristic 
for which the organism is named, Light and electron microscopic studies have 
been interpreted as showing lysis of mucosal cells on contact with amoeba or 
alternatively, a diffuse mucosal damage before amoebic invasion. An 
amorphous, granular, eosionophilic material surrounds trophozoites in tissue, 
whether in colon, liver, lung or brain. Consistent with the fact those 
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trophozoites have the capacity to destroy leukocytes; inflammatory cells are 
found only at the periphery of established amoebic lesions. 
Liver pathology in amoebiasis consists of necrotic abscess or 
periportal fibrosis, the “abscess” contains cellular, proteinaceous debris rather 
than white cells and is surrounded by a rim of amoebic Trophozoite invading 
tissue. Amoebae establish hepatic infection by ascending the portal venous 
system rather than lymphatics. Triangular areas of hepatic necrosis, possibly 
due to ischemia from amoebic obstruction of portal vessels have been observed. 
Amoebic liver abscesses probably result from the coalescence of small micro 
abscesses. Liver function abnormalities are frequently present with intestinal 
amebiasis and are associated with periportal fibrosis has been reported in such 
patients; whether this reflects past trophozoites invasion or host reaction to 
amoebic antigens or toxins is unclear. 
Petri et al isolated the E. histolytica gatactose specific adhesion[22]. The 
adhesin is a 260 -KID surface protein that consists of I7OKD and 35KD 
subunits. The heavy subunit may mediate attachment as it is recognized by 
adherence- inhibitory monoclonal antibodies. Direct galactose binding activity 
of recombinant heavy subunit produced by expression DCR methodology has 
been demonstrated. The heavy and light subunits are encoded by gene families. 
The heavy subunit has a short cytoplasmic domain, a transmembrane domain, 
 36
and a large extra cellular portion with a distinct cysteine- rich area. The light 
subunit in contrast is attached to the membrane via a glycosyl- 
phosphatidylinositol anchor. Petri et a1 identified seven discrete epitopes in the 
heavy subunit using monoclonal Ig antibodies all of which are located in the 
cysteine-rich domain.  
Entamoeba histolytica contains numerous proteolytic enzymes, including 
a cathepsin, proteinase, an acidic proteinase, collagenase and a well 
characterized major neutral proteinase.  
 
Clinical features: 
Amoebic liver abscess is 3 to 10 times as common in man as women. 
Most patients are young adults, although all age groups can be affected. In the 
more affluent, a history of international travel by the patient to his or her close 
contacts may be relevant. Specific questions about homosexual activity should 
be asked. A history of previous dysentery is infrequent and generally unhelpful 
unless accompanied by dependable laboratory reports. 
Symptoms of amoebic liver abscess are slow in onset and usually are 
present for several days or weeks before medical attention is sought[23]. Initial 
complaints are vague and include malaise, fever, anorexia and abdominal 
discomfort. In established cases, pain is most often the dominant symptom and 
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is more in the right hypochondrium about three fourths of patients complain of 
fever, often with chills and sweats, particularly at night. Anorexia, nausea and 
vomiting are common, and many patients lose weight. Chest symptoms are 
present in about one fourth of patients and include right-sided pleuritic pain and 
cough. Diaphragmatic irritation may result in right shoulder pain and hiccoughs 
occasionally. Patients may recognize abdominal swelling. Concurrent intestinal 
disease, such as dysentery or diarrhea, is rare. 
Infrequently, the onset of disease is abrupt and the symptoms mimic 
those of an abdominal surgical emergency[24]. Sometimes patients complain of 
ill health for many months, with constitutional symptoms such as weight loss 
and anaemia predominating. In a small minority of cases, the only 
manifestation is fever. 
On examination , most patients are ill, weak and sweaty, and they may 
appear anaemic and toxic. Fever and tenderness over the liver are almost 
invariable; with the tenderness sometimes being most impressive over the right 
lower intercostals area. Sometimes the liver is visibly enlarged or expands the 
lower rib cage to give the abdomen an asymmetrical appearance.  
Most often the liver is palpable. The physical signs may be subtle when 
the abscess is in the left lobe of the liver. Presence of epigastric and left 
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hypochondrial tenderness may arouse suspicion of enlargement of the left lobe 
of liver. 
In about half of the patients, careful examination of the chest reveals 
abnormalities. Movement of the right side may be limited by pain. Dull on 
percussion over the right lower lung field is common and implies a raised right 
hemidiaphragm or pleural effusion. Occasionally there are fine creptations on 
auscultation or a pleural or pericardial friction rub. 
Jaundice is rare and when present, usually of minor degree. It indicates 
severe illness. Deeper jaundice usually results from multiple or large amoebic 
abscesses or from lesion situated near the inferior surface of the liver with 
compression of the larger intrahepatic ducts. 
Wherever amebiasis occurs in adults, children may also be infected. 
Most reported cases of liver abscess in childhood have been in children under 
age 3, with some affected at only 1 month of life. The sex ratio of cases in 
children is almost equal. Fever and tender hepatomegaly are the usual physical 
signs, with the latter sometimes difficult to elicit in crying child. Associated 
intestinal amoebiasis and multiple hepatic abscesses seem more frequent in 
children than adults, and malnutrition is an important accompaniment, amoebic 
liver abscess often seems a severer disease in childhood[25].  
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When liver abscess occur in pregnancy, frequently such cases are 
misdiagnosed. A Nigerian autopsy study demonstrated a higher prevalence and 
mortality from amebiasis in pregnant compared with nonpregnant women. It 
has been suggested that the immunologic and hormonal alterations of 
pregnancy predispose to invasive disease. Finally, there is a widespread clinical 
impression that amoebic liver abscesses is rare in patients with chronic liver 
disease, although isolated cases have been documented. 
DIAGNOSIS 
Anaemia is common in amoebic liver abscess, with about half the 
patients having hemoglobin values below l2gm/dL. Although usually 
normochromic and normocytic, a hypo chromic blood picture may occur 
despite adequate iron stores. A neutrophilic leucocytosis is usual and a high 
proportion of bands may be seen. Although the white blood cell count is 
between 10,000 and 20,000/ul isolated cases with leukemoid reactions are 
described. Eosinophilia is not a feature of amebiasis. The erythrocyte 
sedimentation rate is raised. 
Results of liver tests oflen are abnormal and of value in focusing 
attention of the liver, although derangements may be minor and nonspecific 
slight elevation of alkaline phosphatase levels and reduction of serum albumin 
levels are the most frequent abnormal. 
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Liver abscess rupture into right pleural cavity – right sided pleural effusion 
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Radiological investigations: 
About half of patients show elevation of the right hemi diaphragm of the 
X-ray chest PA view, the changes in contour being typically most marked 
anteriorly and medially.  Blunting of the right costophrenic angle from a 
sympathetic pleural effusion is common, as are minor right lower lobe 
parenchymal abnormalities from atelectasis. Abdominal films may show 
hepatomegaly but are not helpful. Barium studies and infusion tomography are 
now outdated techniques for diagnosing amoebic liver abscess. 
Technetium sulphur colloid scanning the first modality that allows 
direct assessment of space occupying liver lesions is sensitive but lacks 
specificity. Other hepatic masses, such its as tumors and cysts, may produce 
similar “Cold’ Areas. Gallium scans often are used to complement sulphur 
colloid scans. Unlike pyogenic abcesses and primary hepatocellular cancers, 
amoebic abscesses concentrate gallium only at the periphery of the abscess. The 
disadvantages of these tests include their low specificity,  time delay, and the 
difficulty in working with isotopes[27]. 
Ultrasonogram is fast, safe, economical, and easily repeatable. A 
disadvantage of ultrasonography is operator  dependency. 
Ultrasonic signs mentioned as typical of hepatic amoebic abscess are 1)  
oval or round shape 2) a lack of notable wall echoes, so that there is abrupt  
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LIVER ABSCESS – ULTRASONOGRAM   
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transition from normal liver to the lesion 3) a hypoechoic appearance 
compared with normal liver, with diffuse echoes throughout the abscess. 4) a 
peripheral location, usually close to the liver capsule: and 5) a distal sonic 
enhancement. A typical features that have been documented include on 
irregular shape and a hyper echoic appearance. 
 
Computed tomographic scanning shows amoebic abscesses well defined, 
round, low density lesions, which may have a non homogenous internal 
structure. CT scanning is particularly useful in precise localization and 
definition of extent of disease (eg, is cases complicated by rupture) Both CT 
scan and ultrasonography may be used for guidance in cases in which aspiration 
is indicated. Disadvantages of CT scanning are expensive and the ionizing 
radiation inherent to the investigation[8,28,29]. 
Serodiagnosis: 
Concurrent hepatic abscess and amoebic dysentery are unusual, stool 
examination in large series of patients with amoebic abscesses have been 
negative in three fourths of cases or more. Parasitological examination of the 
stool specimen can neither prove nor exclude hepatic amebiasis, although it 
way be relevant for subsequent management. The quality of practical 
parasitology in hospital laboratories varies widely. Over diagnosis is especially 
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common, with stools leucocytes frequently reported as trophozoites of E. 
histolytica. 
Serodiagnostic tests used include complement fixation, immunodiffusion, 
indirect fluoresent antibody tests, indirect hemagglutination (IHA). 
Counterimmuno electrophoresis, and enzyme — linked immunosorbent assay 
(ELISA). Commercially produced diagnostic kits for use at the bedside, such as 
those using latex agglutination are also available. Clinicians should familiarize 
themselves with local facilities and the accepted sensitivity and specificity of 
the tests in question. 
The IHA test is highly sensitive and widely available. A serologic titer of 
1:512 is usual, although not invariable, in acute invasive disease. Titres may 
continue to rise after presentation, and on occasion, the test is negative when 
the patient is first seen but positive a few days later. The IHA test may remain 
positive for months or years after invasive infection. ELISA is a cheap and 
sensitive technique that has been widely applied to the serodiagnosis and 
seroepidemiologic study of many parasitic diseases. Its use for the diagnosis of 
amebiasis is likely to increase. 
 Role of PCR 
Nested PCR and multiple PCR are helpful in differentiations the various 
species of entameba i.e. E.histolytica .E. dispar., E.meshkorskii(50).  
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Role of aspiration:  
In the era before ultrasonography became widely available, aspiration of 
the typical ‘anchovy sauce’ pus from the liver was often considered vital to 
confirm the diagnosis of amoebic liver abscess. Nowadays, Ultrasonogram-
guided aspiration is often justified on the basis that the diagnosis will then be 
‘more certain’ or that the abscess can be ‘aspirate to dryness’ at the time of 
diagnostic aspiration. The controversy about routine aspiration of 
uncomplicated amoebic liver abscess remains unresolved. Two recent studies 
have shown that aspiration does not accelerate healing, and may only confuse 
the diagnosis by revealing atypical pus or blood. However the belief that 
aspiration hastens clinical recovery and may not involve significant procedure 
related morbidity, is widespread in clinical practice. This approach is supported 
by a recent small prospective study. Clinical improvement invariably occurs 
with antiamoebic therapy alone in an uncomplicated case. When the differential 
diagnoses in a given case include operable neoplasm or hydatid disease, 
aspiration is risky and may even be contraindicated [30,31]. 
Aspiration is therefore now regarded as generally superfluous in the 
management of amoebic liver abscess, and should be reserved for situation 
when 
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Amoebic liver abscess – USG guided aspiration 
 
 
 Anchovy sauce appearance of amoebic liver abscess pus  
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I. Amoebic serology is inconclusive, delayed, or unavailable and the 
main differential diagnosis is a pyogenic liver abscess. 
2. A therapeutic trial with antiamoebic drugs is deemed inappropriate (as 
in pregnancy). 
3. There is suspicion of secondary infection of the liver abscess. This is 
estimated to occur in 15% of cases. 
4. When fever and pain persist for more than 3 to 5 days after starting 
appropriate therapy, aspiration may provide symptomatic relief. 
Single aspiration may be sufficient for diagnostic purposes, but when 
performed as part of therapy is likely to be inadequate. When more than one 
aspiration is required, the placement of a percutaneous drain is probably 
indicated to reduce the risk of recurrence. 
Complications of amoebic liver abscess: 
Communication or extension of amoebic liver abscesses occur into 
neighboring cavities and organs — the peritoneum, viscera and large vessels on 
one side of the diaphragm and the pleura, bronchi, lungs and pericardium on the 
other. 
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Peritoneal and visceral involvement 
Peritonitis associated with amebiasis is due to a rupture of amoebic liver 
abscess in 78% of cases and due to perforated or necrotizing amoebic colitis in 
the rest (22%). The two processes can occur simultaneously in a small minority 
of cases, and this must be kept in mind while making therapeutic decisions for a 
given patient. 
The incidence of spontaneous rupture of amoebic liver abscess varies 
between 2.7 and 17% of cases. Between 18 and 70% of all amoebic liver 
abscess ruptures are into the peritoneal cavity. Adherence of the liver abscess to 
the diaphragm, anterior abdominal wall, omentum and bowel tends to confine 
the area of contamination. Rupture into a hollow viscus such as the stomach or 
colon may occur in this situation with spontaneous drainage. A hepatogastric, 
hepatoduodenal or hepatocolonic fistula may result. Free rupture into the 
peritoneal cavity is uncommon and usually occurs in a nutritionally depleted 
and moribund patient. Patients present with abdominal pain, and either a mass 
or generalized distention. Sudden bloody diarrhea may occur in colonic rupture 
and hematemesis may occur in patients with hepatogastric fistula. Signs of 
peritonitis along with tender hepatomegaly, intercostals tenderness and right 
basal lung signs and clinical jaundice may lead to a suspicion of the diagnosis, 
which will be confirmed on ultrasonography. At times the diagnosis may be 
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made only at laparotomy, at which time the excessive bleeding resulting from 
decreased prothrombin levels can be difficult to manage. 
 
Ultrasonography and CT often show perihepatic fluid collection in cases 
of amoebic liver abscess. It is not possible by these imaging techniques to tell if 
these collections are reactive or actual leaks from the abscess cavity, and the 
differentiation must be made clinically. 
Absolute indications for laparotomy include doubtful diagnosis, 
concomitant hollow viscus perforation with fistulization resulting in life-
threatening hemorrhage or sepsis, or if conservative management fails. At 
laparotomy the liver abscess, which usually appear as a tan-colored bulge on 
the surface.. Septa running across the cavity are usually blood vessels and bile 
ducts traversing the abscess cavity. Hemorrhage can be difficult to control, 
especially if the clotting is disordered and postoperative bile leaks may result. 
Irrigation of the abscess cavity with saline is usually sufficient and may be 
followed by the installation for 3-5 mm of a solution of 65 mg of emetine 
hydrochloride in 100 ml of normal saline. Tube drains are inserted and retained 
as necessary. Hollow viscus perforations must be dealt with on their own 
merits, with exteriorization, proximal diversion or serosal patch closure as 
indicated. 
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Postoperative antiamoebic therapy in the form of intravenous 
metronidazole is combined with broad-spectrum antibiotics. Dehydroemetine is 
added if no cardiac contraindication exists. 
Thoracic and pleuropulmonary involvement 
Thoracic complications associated with amoebic liver abscess include a 
sympathetic straw colored right sided effusion, rupture of the abscess into the 
pleural cavity and rupture of abscess into the bronchial tree. 
Transdiaphragmatic involvement in abscess located high on the right 
lobe is so common as to be part of the clinical syndrome of amoebic liver 
abscess. Clinically, this manifests as dyspnea and a dry cough which 
exacerbates the right hypochondrial pain caused by the hepatic lesion. Right 
basal crepitations are a frequent accompaniment to the abdominal signs. A 
pleural rub may be found which decreases as sings of pleural effusion 
supervene. Chest radiography shows atelectasis and blunting of the 
costophrenic angle. Ultrasonography and CT often pick up the pleural effusion 
before it is clinically detectable. There are no Ultrasonogram or CT features to 
differentiate between a sympathetic effusion and a transdiaphragmatic 
intrapleural rupture except that the former tend to be small and clinically 
insignificant. No treatment is required for this kind of pleural collection other 
than the treatment of the liver abscess on its own merits. 
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Rupture of an abscess into pleural cavity usually occurs suddenly, and 
extends rapidly to collapse the right lung and fill up the right pleural space. 
Clinically, it manifests as the sudden onset of severe dyspnea. Radiography 
reveals a homogenous opacification throughout the right hemi thorax with 
displacement of the mediastinum to the opposite side. Ultrasonography will 
reveal the liver abscess. 
Treatment consists of thoracocentesis. An important precaution to be 
observed both in chest aspiration and establishment of intercostal tube drainage 
is to go in high on the right lateral side of the chest near the axilla, as the right 
diaphragm is considerably elevated in these patients. The tube can easily be 
inserted across the diaphragm into the liver, where it will fail to evacuate the 
pleural collection and may keep the track from the liver abscess from closing. 
Ineffective early drainage of the amoebic empyema is usually complicated by 
secondary infection requiring more aggressive surgical procedures like 
pulmonary decortication at a later date. 
Rupture of the abscess into the bronchi is characterized by the sudden 
onset of coughing with expression of copious quantities of chocolate-colored 
sputum. Although a complication of amoebic liver abscess, it almost always has 
a beneficial effect as the abscess drains itself. As the abscess is usually well 
walled off from both the pleural and peritoneal cavities, surgical intervention is 
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not required and postural drainage, bronchodilators and antiamoebic drugs 
suffice. Lung abscess occurs rarely. In cases where adhesions are not well 
formed, the liver abscess can rupture into both the pleural space and bronchi 
simultaneously and postural drainage of bronchial secretions must be combined 
with thoracocentesis. 
Metronidazole used as a single drug is effective in the treatment of 
thoracic complications of amoebic liver abscess, but emetine produces a more 
rapid response and may be required in cases where metronidazole resistance 
occurs. 
Chemotherapeutic agent 
Metronidazole is the treatment of choice for all forms of invasive 
amoebiasis. It is a nitroimidazole that is well absorbed after oral administration, 
and it is excreted mainly by way of kidneys. 
E.histolytica produces toxic metabolites that interfere with nucleic acid 
synthesis Adverse effects include nausea,. anorexia, metallic taste, dark urine 
and a disulfiram like reaction with alcohol. Central nervous system effects such 
as vertigo, ataxia, and peripheral neuropathy have also been reported. A 
transient leukopenia occasionally is observed. Reports of possible 
carcinogenicity, mutagenicity, and the advantages of metronidazole for severe 
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disease, including in pregnancy, outweigh its, theoretical dangers. In practice, 
the gastrointestinal adverse effects cause the most trouble[33]. 
The usual dosage of metronidazole is 800 mg three times daily for 5 to 
10 days. The usual paediatric dose is 35 to 50 mg/kg/d in three divided doses. 
In very ill patients, some clinicians extend treatment for 15 days or even 
beyond. Patients who cannot take oral metronidazole may be treated with the 
parenteral preparation. Metronidazole is effective treatment for invasive 
intestinal disease but is not completely reliable as a luminal amoebicide[34]. 
Occasional treatment failures have been reported in addition to cases of 
hepatic amebiasis developing after metronidazole therapy for intestinal disease. 
Other nitroimidazoles offer no advantage over metronidazole. The best known 
is tinidazole, which is perhaps associated with less nausea. The usual adult 
dosage is 2 g/day[35]. 
Chloroquine: The antimalarial drug chloroquine, a 4- aminoquinoline, acts by 
binding to parasite deoxyribonucleic acid. High concentrations in liver tissue 
are  obtained after oral administration. It has half life upto 1 week and is 
excreted predominantly through the kidneys.. 
Adverse effects are nausea, abdominal discomfort, and pruritis. 
Retinopathy is only a potential problem in patients taking long term 
chloroquine, as for malaria prophylaxis or rheumatoid arthritis. The usual dose 
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is 1 gm / day for 2 days followed by 500 mg/day for 20 days. The only 
controlled trail of chloroquine versus metronidazole for amoebic liver abscess 
showed no difference in efficacy other than slightly quicker, response with 
metronidazole 
Emetine and dehydroemetine 
Emetine is the oldest as well as the most potent amoebicidal drug 
available. It is given by intramuscular or subcutaneous injection and slowly 
excreted through the kidneys. The drug acts by interfering with protein 
synthesis. The usual dosage is I mg/kg/d to a maximum of 60 mg/day for 10 
days. Duration of the treatment should be kept to a minimum, preferably less 
than 6 days. Adverse effects have rendered this drug obsolete except in the 
severest of cases. Adverse effects include vomiting, diarrhoea, renal 
impairment, and pain or necrosis at the site of injection. The most serious 
adverse effect is cardiotoxicity, any sign of which is an indication for stopping 
the drug. Emetine has no luminal amoebicidal activity. 
Dehydroemetine is a synthetic preparation with a similar action to 
emetine but associated with less cardiotoxicity. It is equally effective 
therapeutically but excreted more rapidly. The daily dose of 1.25 mg/kg is 
given by im or subcutaneous injection to a maximum of 90 mg/d. It should be 
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given in preference to emetine, if available. Cardio toxicity may be more likely 
with concurrent administration of chloroquine. 
Therapeutic strategy: 
Metronidazole is administered as a single drug after diagnosis, with 
concomitant correction of hypoprothrombinemia, hypoproteinemia, and 
anaemia. If dramatic improvement in 48 - 72 hours is noted no other therapy 
other than the complete course of metronidazole is required. A luminal agent 
such as Dilonaxide furoate (500 mgm p.o. tid x 10 days) or paromomycin (30 
mg/kg/day in 3 days x 10 days) must be administered following infection as a 
part of the complete treatment[34,35,36]. 
In patients who do not respond satisfactorily, emetine or dehydroemetine 
is added. Evidence of pulmonary, peritoneal or pericardial extension is all 
indication for aspiration of the liver abscess with an intercostal tube or catheter 
drainage into a closed-circuit collection system. Failure to adequately control 
the abscess by these means — increasing signs or peritonitis, fistulization into a 
hollow viscus or secondary infection with septicemia constitutes as indications 
for Laparatomy. 
PROGNOSIS 
Meta-analysis of 3081 patients with amoebic liver abscess showed that 
114 (4%) died. In comparison, the mortality rate for pyogenic liver abscess was 
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46%. In patients treated with amoebicidal drugs alone the mortality was 2% and 
the addition of needle aspiration did not improve this result. Independent risk 
factors for mortality include serum bilirubin more than 3.5 mg%, 
encephalopathy, hypoalbuminemia less than 2.0 G% and multiple abscess 
cavities. 
Patients treated with a strategy of early and aggressive surgery as 
advocated by Balasegaram (1981) and Eggleston et al (1982) did not show a 
remarkable improvement in mortality although in Balasegaram’s series the 
hospital stay was probably reduced[37]. 
Ruptured amoebic liver abscess occurs in 2-17% of patients, with 
mortality between 6 and 50%. It is hoped that with increasing skill at 
percutaneous drainage of these abscesses the mortality in these patients, who 
usually constitute a major risk for surgery and anesthesia, will be reduced. 
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MATERIAL AND METHODS 
This study was a prospective study done for a period of 2009-2011done 
on patients in Government  Rajaji Hospital , Madurai  
Eighty cases of liver abscess were studied during the period  
DIAGNOSTIC CRITERIA  
All  the patients had several investigations required to approach the 
diagnosis and they were diagnosed as amoebic or pyogenic liver abscess. 
Basically  USG abdomen, serology and pus c/s were done. Serology positive 
and USG characteristics of smooth wall homogenous with no internal echoes 
and superficial solitary abscess were grouped as amoebic . Serology negative 
and pus c/s negative cases with USG characteristics of amoebic abscess were 
also considered as amoebic abscess 
LUNG INVOLVEMENT 
 
X—ray chest PA view was taken in all cases. X—ray findings of right 
pleural effusion, presence or absence of cough with expectorations were 
considered as positive. 
 
 
. 
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TREATMENT SELECTION 
Cases with abscess cavity less than 5 cm were treated by drug therapy 
alone. Failures to relieve symptoms within 3 to 4 days were treated by 
percutaneous aspiration. 
Those with abscess cavity greater than 5 cm were treated either by 
percutaneous aspiration or by percutaneous catheter drainage. Bilateral abscess 
cavities that were small and multiple were managed by medical therapy and 
when any one of the cavity is larger than 5 cm, it was managed by percutaneous 
aspiration. 
Abscess cavities restricted to left lobe were treated by drug therapy if 
they were multiple and less than 5 cm ; if greater than 5 cm and single were 
managed either by percutaneous aspiration or by laproscopic drainage. 
Those abscess cavities that were larger than 10 cm or with chances of 
impending rupture in segment III, IV, V, VI were managed by laproscopic 
drainage. 
ADOPTED THERAPEUTIC PROTOCOL MEDICAL 
 
Abscess cavities that were less than 5 cm were treated by Tab. 
Metronidazole 800 mg for 10 days. 
Patient was on i.v metronidazole for three days initially or till the fever 
subsided. Later oral metronidazole is given and percutaneous aspiration was 
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done and continued if patient had persisting symptoms after 3 to 4 days of 
aspiration. 
 
PERCUTANEOUS ASPIRATION 
Patient with abscess cavity > 5 cm were treated either by percutaneous 
aspiration or PCD. Multiple abscesses and the abscess fail to respond with 
medical treatment were percutaneously aspirated.  
Uunder USG guidance it is done by using 1 6G or 1 8G aspiration needle 
or 3 way adopter as a single prick. First, aspiration was done followed by drugs. 
If symptoms are not decreasing after 3 days, do repeat USG and assess the 
cavity size. 
If the cavity is increasing in size or not decreasing  do 2nd aspiration and 
continue drug therapy. If the symptoms are not subsided by 7th postaspiration 
day and USG showed the cavity is not decreasing or increasing in size, consider 
PCD or laproscopic drainage.  
PERCUTANEOUS CATHETER DRAINAGE 
PCD was done by using Malecots /22 F foleys under Ultrasonogram 
guidance with closed drainage system. 
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LAPAROSCOPIC DRAINAGE OF LIVER ABSCESS 
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POST LAPAROSCOPIC DRAINAGE OF LIVER ABSCESS  
ULTRASONOGRAM FEATURES   
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PATIENT AFTER POST LAPAROSCOPIC 
 DRAINAGE OF LIVER ABSCESS  
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REMOVAL OF PCD 
 
1. If the Quantity is less than 30 ml /8hrs. 
2. IF the drainage is not purulent. 
3. USG and cavitogram were done to assess the cavity size. Note down 
the decrease in size of the cavity and the PCD can be removed. 
 LAPROSCOPIC DRAINAGE 
 
Patients with large abscess greater than 10cm and large abscess that was 
located in the left lobe of liver not amenable to percutaneous drainage were 
treated by laproscopic catheter drainage. Smaller 16 /14 F foleys used for 
abscess drainage and the same criteria of removal similar to that of PCD was 
employed. 
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RESULTS 
 The following observations were made in this study  
Table 1: Age and sex incidence 
Age 
Group  
Male  Female Total 
No. % No. % No. % 
0-30 12 16.66 2 25 14 17.5 
31-40 16 22.22 3 37.5 19 23.75
41-50 24 33.33 1 12.5 25 31.25
51-60 15 20.83 1 12.5 16 20 
61 yrs 5 6.94 1 12.5 6 7.5 
Total  72 100 8 100 80 100 
 
 
Fig 1. Age and sex incidence 
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The mean age distribution of the study group is 40.28 + 7.68 with 
youngest patient at 19 years of age and oldest patient being 69 years of age. 
 Liver abscess in this study was more common in males (90%) than 
females (10%). The commonest age group for liver abscess was 41-50 yrs 
(31.25%) followed by 31-40  (23.75%).  
Symptoms: 
 
Table 2: Incidence of symptoms  
Symptoms No. of patient % 
Fever  57 71.25 
Pain abdomen  53 66.25 
Jaundice  12 15 
Cough  3 3.75 
Diarrhoea  14 17.50 
Altered sensorium 1 1.25 
 
 
Fig 2. Incidence of symptoms 
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 The commonest symptom was fever(71.25%) followed by pain abdomen 
(66.25%). Jaundice was present in 15% ,diarrhea occurring in 17.50%, cough 
in 3.75%  and altered sensorium 1.25%.    
Table 3: Distribution of signs  
Signs No. of Patient % 
Fever  60 75 
Icterus  15 18.75
Pallor  6 7.5 
Hepatomegaly 26 32.5 
Abdominal tenderness 32 40 
Respiratory findings  3 3.75 
  
 
 
 
Fig. 3: Distribution of signs 
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 The most common sign was fever which was present in 75% patients, 
40%  of patients had abdominal tenderness at the time of diagnosis  and 32.5% 
patients had hepatomegaly, 18.75%  of patients had icterus, pallor was present 
in 7.5% of  patients and respiratory findings in 3.75% of patients which  
include right pleural effusion, basal crepitations. 
 
Table 4: Duration of symptoms  
Onset  No. of patient % 
Acute < 7 days  42 52.5 
Subacute   
( 7 days – 2 months)  
19 23.75 
Chronic > 2 month  19 23.75 
 
 In this study patients presented acutely with onset of symptoms <7 days in 
52.5% of cases. Sub acute presentation between 7 days – 2 months was noted 
in 23.75% of patents and those with chronic duration of onset > 2 months were 
seen in 23.75% of patients. 
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Table 5: Alcoholism  
Alcoholism No. of patient % 
Alcoholic  51 63.75 
Non alcoholic 29 36.25 
 
 Out of 72 males patients, 51 patients were alcoholics. No female patients 
were found to be alcoholic.  
 
Fig . 4: Alcoholism 
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Table 6: Percentage of abnormal laboratory investigations. 
Investigation  No. of patient % 
Anaemia (Hb < 10 gm%) 8 10 
Leucocytosis (> 12,000 c/cmm) 57 71.25
Diabetic (RBS > 200 mg/ dl) 13 16.25
Raised urea ( > 60 mg / dl) 9 11.25
 
 Hemoglobin less than 10gm% was found in 8 cases (10%) and lowest 
hemoglobin noted in this series was 7.6 gm%. Leucocytosis of more than 
12,000 cells / cumm was present in 57 patients (71.25%). The highest count 
noted in this study was 19,000 cells / cumm, 16.25% of patients were found to 
be diabetic. Raised urea (> 60mg/dl) was found in 9 cases (11.25%). 
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Table 7 : Analysis of LFT 
Serum Bilirubin / mg% No.of patient % 
< 1 64 80 
1.3 – 2 1 1.25 
2.1 – 4 9 11.25 
4.1 – 6 5 6.25 
6.1 – 8 1 1.25 
 Clinically jaundice was detected in 15 patients with elevated bilirubin 
levels.  
 
 
 
 
 
 
 
  Alkaline phosphatase was found to be raised in 28.75% of cases 
Hypoalbuminemia (< 3gm/dl) was observed in 8.75% cases.  Increased  
 Prothrombin time > 20 sec was seen in 16.25% of cases. Increased SGOT and 
SGPT were seen in 16.25% and 11.25% of patients respectively . 
Investigation No.of patients % 
ALP (Alkaline phosphatase) 23 28.75 
Hypoalbuminemia (< 3gm / dl) 7 8.75 
Increased PT time (> 20 sec)  13 16.25 
Increased SGOT (> 40 IU/I) 13 16.25 
Increased SGPT (> 40 IU/L) 9 11.25 
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Table 8 : Chest X-ray  
Chest X-ray No. Of patient  % 
Elevated hemidiaphragm 9 11.25 
Pleural effusion  3 3.75 
 
Chest X-ray showed elevation of the right hemi diaphragm in 9 cases 
(11.25%) Obliteration of right costophrenic angle was seen in 3.75% of cases. 
Table 9: Ultrasonogram Examination 
 Ultrasonogram examination was done in all cases. It showed evidence of 
abscess in liver in all the cases. 
 
Location No. of patient % 
Right lobe 59 73.7 
Left lobe 9 11.25 
Both lobes 12 15 
Total 80 100 
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Fig –5   Location of abscess 
 
 Right lobe of the liver was more involved than left lobe of liver. Right 
lobe involvement was present in 73.75% ,  left lobe in 11.25%  and both lobes 
in 15% of cases . 
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Table 10: Solitary and multiple abscess  
Number No. of patient % 
Solitary  63 78.75 
Multiple  17 21.25 
Total  80 100 
  
 
 
                          
Fig . 6 : Distribution of abscess  
 
 78.75% of cases of liver abscess showed solitary abscess in 
Ultrasonogram examination and 21.25%  cases showed multiple abscesses. 
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Table 11: Pus culture Analysis  
Organism No.of  patient % 
No growth / Anchovy sauce 44 84.6% 
Non- fermenting gram –ve 6 11.53% 
Staph aureus  2 3.84% 
Total 52 100% 
 
In this study 52 cases were subjected to invasive treatment. Out of 52 cases, 
44(84.6%)  had “Anchovy sauce” appearance of the pus and revealed no 
growth. While growths were obtained in 8 (15.37%) of these cases, non-
fermenting gram –ve organisms grown in 6 cases (11.53%) and staph aureus in 
2 cases (3.84%). 
Table 12: Analysis of treatment 
Treatment  No. of patient  % 
Conservative  28 35 
Aspiration 39 48.75 
Laparatomy 6 7.5 
Laparoscopic abscess drainage  7 8.75 
Total 80 100 
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Fig. 7: Treatment of liver abscess 
 
Out of 80 cases, with liver abscess, the volume is < 50 cc is 28 cases 
(35%)  were treated conservatively and those  with volume > 50cc were 
treated by USG guided aspiration is 39 cases (48.75%). 6 cases were 
treated by Laparatomy and 7 cases by laparoscopic abscess drainage.  
Abscess ruptured into peritoneal cavity in 6 cases hence laparotomy done. 
Pus was completely drained out and sent for microbiological examination, 
peritoneal toilet was given. 
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Table 13: Complications  
Complications No.of 
patient
% 
Ruptured into peritoneal cavity  6 7.5 
Pleural effusion 3 3.75 
Septicemia  1 1.25 
 
  Table 14: Mortality rate  
Total patient with liver abscess 80 
Surviving  79 
Death due to liver abscess  1 
 
Table 15: Analysis of repeat aspiration  
Treatment No.of patient 
Second aspiration  3 
More than two aspirations  6 
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DISCUSSION 
Age and sex incidence 
The age of the patients varied from 19 – 69 years.. The mean age 
was 40.28 + 7.68 yrs. The highest incidence was noted in the age group 41-
50 years of age (33. 33%) followed by 31-40 years of age (23.75%) yrs in 
this study. The mean age was lower when compared to other studies. 
Bhagwan et al showed mean age of 49 years and the distribution was 
highest between 41-50 years of age[38] .  
• According to Walter D Gaisford James B.D, Mark, the male female 
ratio is 7:1 whereas in our study we found out that the difference is 9:1 
ratio[39].  
Table 16: The comparison of symptoms and signs in present study with 
literature 
Symptoms Our  series Greenstein – et al Rubin 
et al 
No of cases (%) % %
Fever 71.25 95 87
Pain abdomen 66.25 84 47
Jaundice 15 24 20
Cough 3.75 37 24
Signs    
Fever 75 95 87
Icterus 18.75 24 20
Abdominal 
Tenderness 
40 42 47
Hepatomegaly 32.5 39 51
Respiratory finding 3.75 37 24
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Greenstein et al and Rubin et al observed in their studies that fever was 
present in 95 & 87% of patients respectively whereas in our study we found 
out a less incidence of fever in 71.25% of patients[40]. Pain abdomen was 
noticed in 66.25% of patients whereas Greenstein et al. observed a high 
presentation of pain abdomen in 84% of cases while Rubin et al. observed 
47% [41]. Cough was not a significant presentation in our study which was 
present in 3 patients.  Other symptoms and signs were comparable to other 
studies. 
Duration of symptoms 
The onset of the disease is subjected to great variations depending 
upon the type, location and quantity of liver abscess; it may be acute, 
insidious, clinically undetectable or fulminant form. In this present study 
acute onset <7 days was seen in 52.5%, sub acute onset 7 days — 2 months 
was seen in 23.75% of patients and the same 23.75% with the chronic 
presentation of liver abscess.   
According to Bhagwan satiani, Eugene D. Davidson, duration of 
symptoms prior to admission varied considerably from one day to three 
months[38]. 
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According to Maingot’s abdominal operations, most patients of liver 
abscess manifest symptoms for less than 2 weeks but a more indolent 
course occurs in 1/3rd of the patients[42]. 
Alcoholism in cases of liver abscess 
Alcoholism was found to be the most consistent etiological factor in 
this study of liver abscess. 63.75% of the cases of this study were found to 
be alcoholics. The presence of alcoholism as a risk factor was noticed in 
many studies. In Indian culture almost all the alcoholics are males. It can 
explain the high incidence of liver abscess among the males in comparison 
to the western literature. According to Shyam Mattur,  Alok Mehta et al, 
the percentage of alcoholics in the patients of liver abscess was noted 
between 48-71 % of cases[43]. Poor hygiene and eating unhygienic foods 
were the source of contamination for both the parasitic and bacterial cause 
of the disease, also plays a significant role in causing liver abscess.  
Analysis of laboratory investigations: 
10% of patients were found to be anaemic (Hb < 10gm /dl) in our 
present study. The mean Hb of the patients in this study was 10.4 gm/dl 
with a range 8.8-13.6 gm%.. According to Bhagwan satiani and Eugene D. 
Davidson, anaemia was present in 39% of cases[38]. There is less literary 
evidence suggesting anaemia is a predisposing factor for liver abscess. But 
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high incidence of anaemia is noted in many of the cases, and the relation is 
not well understood. Leukocytosis was observed in our cases which was 
comparable to other studies.  
Diabetes Mellitus was observed in 16.25% of patients. The increased 
association of diabetic state with liver abscess shows that diabetes is a risk 
factor for liver abscess. According to A.J. Greenstein, D Lowenthal, BA, 
G.S. Hammer, F. Schaffner and A. H. Aufses, Diabetes was found in 10% 
of cases[40]. 
Observations by Bhagwan Satiani and Eugene D.Davidson revealed 
elevated serum bilirubin was seen in 36% of cases, whereas in our study 
the elevated bilirubin levels were noted in 19 patients[38].  
Raised ALP levels were noted in 28.75% of patients and 
observations by Bhagwan Satiani and Eugene D. Davidson increased levels 
of ALP was seen in 63% of cases[38]. According to Chu KM, Fan ST 
Hypoalbuminemia was an adverse prognostic factor in eases of liver 
abscess[44]. Increased prothrombin time > 20 was seen in 16.25% increased 
SGOT in 30% increased SGPT in16.25% of patients.  
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Chest X-ray finding: 
Chest X-ray was done for all patients in this study and the X-ray 
findings were studied. Chest X-ray showed elevation of the right 
hemidiaphragrn in 9 cases (11.25%). Obliteration of right costophrenic 
angle was seen in 3 cases (3.75%). 
According to A.J. Greenstein, D. Lowenthal, G,S. Hammer, F. 
Schaffner and A. H. Aufses, elevation of right hemidiaphragm was seen in 
40% of cases and right pleural effusion in 24% of cases[40]. 
Table 17: USG Findings of liver Abscess  
 Present study Bhagwan 
satiani et al No of cases  (%) 
Right lobe  73.75 79 
Left lobe  11.25 5 
Both lobes  15 16 
 
Ultrasonogram abdomen was done to all patients in this study. In the 
present study right lobe was involved in 73.75% of cases. This is in 
accordance with the study concluded by Bhagwan Satiani et al who 
recorded 79% involvement in right lobe. 
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In present study left lobe and both lobes were involved in 11.25% 
and 15 % of patients respectively where as 73. 75% of patients had abscess 
cavity in the right lobe.   
 
In the present study solitary abscess and multiple abscesses were 
present in 78.75% and 21.25% of cases respectively. This is in accordance 
with the study conducted by Chaturbhuj Lal Rajak et a1 who recorded 72% 
solitary and 18% multiple abscesses[45]. 
Pus culture analysis   
In this study 52 cases were subjected to invasive treatment out of the 52 
cases 84% cases had anchovy sauce appearance of pus and revealed  no 
growth . Growth was 15.37% of cases. Non fermenting gram (-) organisms 
found in 11.53% and Staph aureus found in 3.84%.  
Analysis of treatment 
Surgical drainage of liver abscesses has been an accepted therapy for 
decades. The diagnosis and treatment of liver abscess has changed due to 
advances in imaging techniques. 
In the present study of 80 cases patients who had multiple small 
abscess and solitary abscess with volume <50 ml were treated 
conservatively. The conservative management was done on 35% of cases. 
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All cases were started on metronidazole IV at a dose of 40 mg/kg/wt (2.0 
—2.5gm/day in divided doses for  8-10 days). When patients did not show 
improvement in 24-48 hrs of metronidazole therapy, broad spectrum 3rd 
generation cephalosporins were started.  
According to Hiroshi Okano, Katsuya Shraki percutaneous aspiration 
is not required in all cases of liver abscess. A subset of cases with small 
liver abscess < 300 cc can be successfully managed conservatively[46]. 
In 48.75% patients who had abscess >50 cc were chosen for 
percutaneous aspiration. The site, depth and direction of aspiration were 
marked under USG guidance, aspiration needle was usually used and under 
aseptic precautions, the abscess cavity was entered. Local anesthetic was 
used, pus was aspirated and sent for culture and sensitivity; no 
complication were noted due to this procedure apart from local pain which 
soon subsided after analgesics. Patient showed improvements in their 
symptoms and signs within 48-72 hrs of the aspiration. Percutaneous 
catheter drainage was not done on any patient in this study. Laparotomy as 
the initial line of treatment was performed in 6 (7.5%) of cases of liver 
abscess ruptured into peritoneal cavity. On laparotomy, thorough peritoneal 
lavage and drains were kept. 
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According to Arshed Zafar, Sajjad Ahnied, needle aspiration is safe, 
rapid effective method of treating liver abscess. Routine aspiration is not 
indicated. It should be initial line of treatment in abscess > 300 cc, 
impending rupture or abscess that do not respond to chemotherapy. 
According to Antonia, Giorgio, Lucien Turuntino percutaneous 
needle aspiration is an efficient, effective and low cost technique that can 
even be performed on an out patient basis [48]. It is safe, free from 
significant complication. 
Laparatomy was done in 6 cases for liver abscess  which ruptured 
intraperitoneally.  Laparoscopic liver drainage was done in 7 patients which 
is technically difficult for the young laparoscopic surgeons.  
Analysis of Repeat Aspirations 
A Single repeat aspiration was sufficient in 3 patients while in 6 
patients, multiple repeat aspirations were required. Thick viscous pus was 
the main reason for repeat aspirations. 
According to Chaturbhuj Lal et al, in their study on liver abscesses 
found that single aspiration was successful in 88% of cases while 10% 
required 2 aspirations[45]. 
Discussion of complications 
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The complications in our study were rupture of liver abscess into 
peritoneal cavity and pleural effusion. Six case presented with peritonitis 
for which laparotomy was done and peritoneal lavage was given. 
Septicemia with multiorgan dysfunction was seen in 1 case. Pleural 
effusion was observed in 3 cases.  
According to  Sharma MP, Dasarthy S, Verma N et al, mortality rate 
in their study was 0-18 % and in our study one case ( 1.25%) had the end 
result of mortality due to liver abscess after intraperitoneal rupture[49].  
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CONCLUSION 
 
This study is based on the reports of 80 patients treated for liver 
abscess at Govt. Rajaji Hospital, Madurai. 
 The most common age group affected by Liver abscess was 
between 41-50 years.  
 The male-female sex ratio found in this study was 9:1.  
 The most common symptom was fever, followed by pain 
abdomen.  
 Among the risk factors studied, alcohol consumption was 
observed in the most number of patients.  
 Solitary abscesses were common compared to multiple 
abscesses. 
 The right lobe was more commonly affected.  
 2/3 of the patients needed invasive management. 
 Multiple small abscesses and solitary abscess with volume less 
than 50 ml were managed successfully on conservative 
antimicrobial therapy alone. 
 87
 Complications like intraperitoneal rupture, pleural effusion 
septicemia, and death can occur. Mortality rate in this study 
was 1.25%. 
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ANNEXURE  
PROFORMA  
 
Patient’s Name  :    Address : 
Age :       Hospital : 
Sex :       Ward No : 
Occupation :      Unit : 
Locality : Urban / Rural     D.O.A : 
Religion :      D.O.D : 
Duration of stay in hospital :   Socio economic status: 
 
CHIEF COMPLAINTS : 
HISTORY OF PRESENTING ILLNESS: 
Symptoms  
1. Abdominal Pain : Yes / No 
 Duration : 
 Site : 
 Character : 
 Radiation :  
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2.   Fever : Yes / No 
 Duration :  
 Type : 
 Associated with chills and rigors :  
3. Diarrhoea / Dysentery :  
 Duration : 
 Mucous diarrhea : 
 Blood in stools :   
4. Vomiting : 
 Duration / Frequency : 
 Color : 
5. Jaundice :    Yes / No 
6. Cough :   Yes / No 
7. Distension of abdomen: Yes / No 
8. Altered Sensorium : Yes / No 
9. Any Other : 
 
PAST HISTORY  
 Diarrhea : Yes / No 
Jaundice :  Yes / No 
Diabetes : Yes / No 
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Tuberculosis : Yes / No 
Surgery :  Yes / No 
Trauma : Yes / No 
FAMILY HISTORY : 
Similar illness : 
Other :  
PERSONAL HISTORY : 
ALCOHOL CONSUMPTION:  
Duration   
Amount   
 
GENERAL PHYSICAL EXAMINATION : 
Pallor :     
Jaundice :      
Respiration :  per minute  
Temperature :   
LOCAL EXAMINATION : 
ABDOMEN: 
INSPECTION : 
1. Shape : Scaphoid / flat / distended / obese 
PALPATION : 
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1. Tenderness :  Present / Absent  
2. Rigidity :   Present / Absent  
3. Liver :   Palpable / non palpable  
    Upper limit of percussion in rt MCL : LCS 
    Lower limit of percussion below costal margin: cms 
    Liver span :   cms  
    Borders :   sharp / rounded  
    Surface :  Smooth / Nodular  
 
RESPIRATORY SYSTEM : 
1. Shape and expansion of chest : 
2. Air entry : 
3. Breath sounds : 
4. pleural effusion :  Present / Absent  
 
INVESTIGATIONS: 
1. Blood : 
Hb :  gm% 
T.C. :  c/cmm 
D.C. :  N%, L%, E%, M%, B% 
ESR  :  mm/hr 
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Prothrombin time : Sec 
INR : 
FBS :    mg% 
Blood urea  :   mg % 
SPECIAL INVESTIGATIONS:   
Liver Function Tests: 
1. Serum Bilirubin :  mg% 
2. Albumin :   gm% 
3. Alkaline phosphatase : IU/L 
4. S.G.O.T.   IU/L 
5. S.G.P.T.   IU/L 
6. PT :  IU/L 
RADIOLOGICAL INVESTIGATIONS: 
1. Plain X-ray Chest PA view : 
2. ULTRASONOGRAPHY ABDOMEN : 
TREATMENT : 
MEDICAL TREATMENT: 
SURGICAL TREATMENT  
COMPLICATIONS :  
 Early :  
 Late post operative : 
 99
FOLLOW UP : 
COMMENTS: 
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KEY TO MASTER CHART  
-  - Absent  
+  - Present 
ALP  - Alkaline Phosphatase  
B  - Both lobes  
CxR  - Chest X-ray 
DUR  - Duration  
EHD  - Elevated hemi diaphragm 
Hb  - Hemoglobin 
L  - Left lobe 
M  - Multiple abscess  
NAD  - No abnormal defects 
PR                 -          Peritoneal rupture  
PT  - Prothrombin time  
RBS  - Random blood sugar  
RPE  - Right pleural effusion  
R  - Right lobe  
S  - Single  
S. Alb  - Serum Albumin  
WBC   - White blood count  
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1 O22825 32 M + + 67 + ‐ Yes 10 11,000 80 23 O.3 Yes No Yes Yes No EHD R S Conservative Nil No No grwth
2 O25626 41 M ‐ + 4 ‐ ‐ No 10.4 12,500 254 16 4.2 No No No No No NAD R S Conservative Nil Yes No grwth
3 O25815 55 M + ‐ 3 + + No 9.6 13,000 70 28 O.4 No No No No No NAD R S Aspiration Nil No No grwth
4 O32274 35 M ‐ ‐ 3 ‐ ‐ Yes 11 13,500 90 15 1.6 Yes Yes No No No NAD R S Aspiration Nil No No grwth
5 O35800 23 M + + 87 ‐ ‐ No 11.2 13,000 98 70 O.6 No No Yes No Yes NAD B M Conservative Nil No No grwth
6 O38902 23 M + ‐ 14 + ‐ No 10.3 12,500 106 29 O.7 No No No No No NAD R S Aspiration nil No Non Ferm Gm‐ve
7 O42131 36 F + + 6 ‐ + Yes 11 8,000 227 26 O.4 No No No No No NAD R S Conservative Nil No No grwth
8 O45550 47 M ‐ + 4 + ‐ No 10.3 19,000 105 130 7.4 Yes No Yes Yes Yes NAD R S laparotomy Septicemia No No grwth
9 O47201 49 M + ‐ 45 + ‐ No 9 10,500 140 69 0.4 No No No No No EHD R S Conservative Nil No No grwth
10 O56522 39 M ‐ + 76 + + Yes 10.8 11,000 120 19 2.1 No No Yes No Yes RPE R M laparotomy PR No No grwth
11 O69585 48 M + ‐ 3 + ‐ No 11.3 13,500 110 29 O.5 Yes No No No No NAD R S Aspiration Nil No No grwth
12 O71212 37 M ‐ + 4 ‐ ‐ Yes 10.5 13,000 89 19 O.6 No Yes No No No NAD R S Conservative Nil No No grwth
13 O53356 52 M + + 23 + ‐ No 11.6 12,800 270 29 O.3 No No Yes No No NAD R M laparotomy Peritoneal rupture No No grwth
14 O56264 44 M + ‐ 4 + ‐ No 11.2 12,400 85 74 2.5 No No No Yes No NAD R S Aspiration Nil No No grwth
15 O62331 35 M + + 85 ‐ ‐ Yes 10.4 13,000 96 10 O.5 Yes No No No No NAD R S Aspiration Nil No No grwth
16 O62472 31 M ‐ + 42 ‐ ‐ No 10.6 13,500 86 14 O.6 No No Yes No Yes EHD R S Conservative Nil Yes No grwth
17 O69302 25 M + + 67 + ‐ No 10.2 9,000 89 30 2.8 Yes Yes No Yes No NAD L M laparoscopy Nil No No grwth
18 O69562 46 M ‐ + 5 ‐ ‐ Yes 10.4 10,500 110 33 O.5 Yes No No No No NAD B S Conservative Nil No No grwth
19 O91970 33 M + + 13 + + No 10 12,600 120 20 O.6 No No No No Yes NAD R S Conservative Nil Yes No grwth
20 O94831 27 F ‐ ‐ 5 ‐ ‐ No 9.8 12,800 70 29 2.7 No Yes No No No NAD R S Aspiration Nil No No grwth
21 O95717 44 M ‐ + 87 ‐ + No 10.1 13,600 98 15 O.7 No No No No No NAD R S Aspiration Nil No No grwth
22 O105374 34 M + + 13 + ‐ Yes 10.3 7,000 220 18 O.7 No No No No No NAD R S Conservative Nil No No grwth
23 O11427 45 M + + 5 + + No 10.5 13,500 79 16 2.3 Yes No No No No NAD R M laparotomy PR No No grwth
24 O27720 58 M + ‐ 4 + ‐ No 9 14,000 280 29 O.7 No No No No No NAD B S Conservative Nil No No grwth
25 O67546 18 M ‐ + 6 + ‐ Yes 11.2 12,800 86 19 3.2 No No No No No NAD R S Aspiration Nil No No grwth
26 O75661 33 M + + 33 ‐ ‐ No 10 11,000 160 29 O.4 No No No No No NAD R S Conservative Nil No No grwth
27 O80098 42 M + ‐ 64 + + Yes 10.4 13700 80 55 2.9 Yes No No No No NAD R S laparoscopy Nil No No grwth
28 O10190 28 M + ‐ 36 + ‐ No 11.4 13,500 78 29 O.4 No No No No No NAD B S Aspiration Nil No No grwth
29 O78212 57 M ‐ + 4 ‐ ‐ No 11 9,000 104 29 O.7 No No Yes No No NAD R S Aspiration Nil No No grwth
30 O79687 37 M + + 97 + + No 10.4 12,500 110 69 O.4 Yes No No No No EHD R S laparoscopy Nil Yes No grwth
31 O91966 19 M + ‐ 6 + ‐ No 12 13500 120 29 O.7 No No No No No NAD R S Conservative Nil No No grwth
32 OO9170 46 M + + 76 + ‐ Yes 10.3 11000 140 19 O.2 Yes No No No No NAD R S Aspiration Nil No No grwth
33 O10812 31 M + + 6 ‐ + No 10.4 14000 90 39 O.8 No No Yes No Yes NAD R M Aspiration Nil No No grwth
34 O13989 56 M + ‐ 34 + ‐ Yes 10.6 14500 254 25 O.5 No No No No No NAD L S laparoscopy Nil No No grwth
35 O14006 29 M + + 5 + ‐ No 8 13600 140 19 O.7 No No No No No NAD R S Aspiration Nil No No grwth
36 O29981 35 M ‐ + 87 ‐ + No 10.2 13900 120 15 O.8 No No No No No RPE R S Aspiration Pl.  Eff. No Staph. Aureus
37 O30024 48 M + + 4 + ‐ Yes 10.6 12900 110 30 O.5 No No No No No NAD L S laparoscopy Nil No No grwth
38 O52541 59 M + ‐ 67 + ‐ No 12 15500 324 20 O.6 Yes No No Yes Yes NAD L S Conservative Nil No No grwth
39 O16068 39 M ‐ + 4 + + No 11.5 9000 124 29 O.4 No No No No No EHD R M laparoscopy Nil No No grwth
40 O46813 45 M + ‐ 12 + ‐ Yes 10.6 13000 140 35 O.3 No No No No No NAD R S Aspiration Nil Yes No grwth
41 O46919 51 M + + 4 + ‐ No 10.4 14000 80 43 O.5 Yes No No No No NAD B S Aspiration Nil No No grwth
42 O51487 25 M + + 4 ‐ ‐ No 11 13700 68 43 O.2 No No Yes No Yes NAD L M Aspiration Nil No No grwth
43 O62779 54 M ‐ ‐ 5 + ‐ No 11.8 8600 89 49 O.7 No No No No No NAD R S laparotomy PR No No grwth
44 O64826 42 M + + 88 + ‐ Yes 12.2 13100 324 39 4.5 No No No No No NAD R S Conservative Nil No No grwth
45 O67502 57 M ‐ ‐ 6 ‐ + No 10.4 12000 89 29 O.5 Yes No No No No NAD B M Aspiration Nil No No grwth
46 O69096 37 M + + 3 + ‐ Yes 10.9 12300 230 20 O.5 No No No No No NAD R S Conservative Nil No No grwth
47 O62977 26 M + + 43 + ‐ Yes 10.4 15000 114 40 O.2 No No Yes No Yes NAD L S Aspiration Pl. Eff. No No grwth
48 O13799 49 M ‐ + 87 ‐ ‐ No 7.8 7000 108 22 5.4 Yes No No No No NAD R S Conservative Nil No No grwth
49 O16885 54 M + ‐ 67 + ‐ No 10.4 12000 78 21 O.6 No No No No No NAD R S laparoscopy Nil Yes No grwth
50 O32180 45 M + + 4 + ‐ Yes 10.5 10000 77 90 O.7 No No No No No NAD R S Aspiration Nil No Non Ferm Gm‐ve
51 O48824 36 M + ‐ 12 + ‐ No 11 15200 209 30 O.6 No No No No No NAD R M Conservative Nil No No grwth
52 O53118 52 M + + 6 ‐ ‐ No 11.2 11000 89 36 O.4 Yes No Yes No Yes EHD R S Aspiration Nil No No grwth
53 O55240 43 M + + 87 + ‐ Yes 11.5 12000 97 82 O.3 No No No No No NAD R S Aspiration Nil No No grwth
54 O56435 62 F + + 3 ‐ + No 12.4 12500 250 39 O.8 No No No No No NAD B M Conservative Nil No No grwth
55 O59224 41 M ‐ + 31 + ‐ No 11.7 12400 115 18 O.9 No No No No No NAD R S Aspiration Nil No Non Ferm Gm‐ve
56 O62519 66 M + ‐ 3 + ‐ Yes 10.5 10050 140 34 3.6 Yes No No No No NAD R M Aspiration Nil No No grwth
57 O11380 47 M ‐ + 78 + ‐ No 7.8 14000 280 14 O.3 No No No No No EHD R S Conservative Nil No No grwth
58 O12456 64 M + + 34 + ‐ No 11.3 15000 224 19 O.5 No No No No No NAD L S Aspiration Nil No No grwth
59 O41311 26 F ‐ + 4 ‐ ‐ Yes 11.4 11000 110 33 O.6 No No Yes No Yes NAD R S laparotomy PR No No grwth
60 O48210 20 M + + 4 + ‐ No 10.2 12500 105 39 O.4 Yes No No No No NAD R S Conservative Nil No No grwth
61 O48197 22 F + + 6 ‐ ‐ No 10.5 10500 144 68 O.6 No No No Yes No NAD L S Aspiration Nil No No grwth
62 O49717 57 M + + 34 + ‐ Yes 12.8 11000 117 20 O.7 No No No No No NAD R M Conservative Nil Yes No grwth
63 O39872 39 M ‐ + 6 15200 ‐ No 11.3 15500 105 69 O.2 No Yes No No No NAD R M Aspiration Nil No No grwth
64 O49724 49 M ‐ + 54 + ‐ No 10.5 12000 98 59 O.6 No No No No No NAD R S Aspiration Nil No No grwth
65 O49899 69 M ‐ ‐ 3 + ‐ Yes 10.2 13000 154 26 O.5 No No No No No NAD B S Conservative Nil No No grwth
66 O32199 57 M + + 6 + ‐ No 10.8 15000 86 39 O.7 No No No No No NAD B S Aspiration Nil No Non Ferm Gm‐ve
67 O48834 22 M ‐ + 3 ‐ ‐ Yes ]11.6 14500 69 25 O.8 Yes No No No No EHD R M Aspiration Nil No No grwth
68 O53418 42 M + + 3 + + No 11.9 12500 89 53 O.6 No Yes No No No NAD B S Conservative Nil No No grwth
69 O55540 32 F + + 97 ‐ ‐ No 13.4 15000 104 22 5.2 No No No No No NAD R S Aspiration Nil No No grwth
70 O56635 59 M + + 3 ‐ ‐ Yes 13.5 13000 114 25 O.4 No No Yes No Yes NAD R M Aspiration Nil No No grwth
71 O59264 68 M ‐ ‐ 1 ‐ ‐ No 10.2 11300 189 30 O.6 No No No Yes No RPE B S Conservative Nil Yes No grwth
72 O62523 43 M + + 78 + ‐ No 10 12600 164 10 4.8 No No No No No NAD R S Aspiration Nil No No grwth
73 O11450 47 F ‐ + 26 ‐ ‐ Yes 10.3 12050 112 16 O.7 Yes No No No No EHD R S Conservative Nil No No grwth
74 O12786 52 M + + 4 + ‐ No 10.5 13000 135 19 O.8 No No No No No NAD B S Aspiration Nil No No grwth
75 O41671 41 M ‐ ‐ 2 + ‐ No 10.5 14300 96 34 1.9 No Yes No Yes Yes NAD R S Aspiration Nil Yes No grwth
76 O48910 36 F + + 3 ‐ ‐ No 11.2 13500 92 20 O.4 Yes No No No No NAD R S Aspiration Nil No No grwth
77 O48168 56 F ‐ ‐ 76 ‐ ‐ No 11.5 12400 105 39 O.6 No No No No No NAD R S Conservative Nil No No grwth
78 O49734 45 M + + 34 + + Yes 11 15000 78 28 O.8 No No No No No NAD R S Conservative Nil No No grwth
79 O39884 38 F + + 87 ‐ ‐ No 7.6 12500 139 20 O.7 Yes No No No No NAD R M Aspiration Pl. Eff. No No grwth
80 O45566 46 M ‐ ‐ 3 + ‐ No 10.7 13000 129 28 O.7 Yes No No Yes No NAD L S Aspiration Nil No No grwth
